Function of metallothionein-3 in neuronal cells: Do metal ions alter expression levels of MT3?

International Journal of Molecular Sciences

Volumn 18, Issue 6, 2017, Pages

  Bousleiman, Jamie ^a   Pinsky, Alexa ^a   Ki, Sohee ^a   Su, Angela ^a   Morozova, Irina ^b   Kalachikov, Sergey ^b   Wiqas, Amen ^a   Silver, Rae ^a,c,d   Sever, Mary ^a   Austin, Rachel Narehood ^a  

^a Program on US Russia Relations at Columbia s Harriman Institute   (United States)

^b Department of Earth and Environmental Sciences   (United States)

^c Department of Pathology and Cell Biology Columbia Health Sciences ^*  (United States)

^d NONE   (United States)

Author keywords

Dentate gyrus; Gene expression; Lead neurotoxicity; Metalloneurochemistry; Metallothionein; Microarrays; MT3

Indexed keywords

COBALT CHLORIDE; COMPLEMENTARY DNA; LEAD ACETATE; LITHIUM SULFATE; METAL ION; METALLOTHIONEIN II; METALLOTHIONEIN III; ZINC SULFATE; ION; METAL; METALLOTHIONEIN; ZINC;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; MOUSE; NERVE CELL; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; ZINC HOMEOSTASIS; ANIMAL; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN HOMEOSTASIS;

ANIMALS; DENTATE GYRUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IONS; METALLOTHIONEIN; METALS; MICE; NEURONS; PROTEOSTASIS; ZINC;

EID: 85019681969     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18061133     Document Type: Article

References (72)

1. Masters, B.A.; Quaife, C.J.; Erickson, J.C.; Kelly, E.J.; Froelick, G.J.; Zambrowicz, B.P.; Brinster, R.L.; Palmiter, R.D. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J. Neurosci. 1994, 14, 5844-5857.
2. Babula, P.; Masarik, M.; Adam, V.; Eckschlager, T.; Stiborova, M.; Trnkova, L.; Skutkova, H.; Provaznik, I.; Hubalekadi, J.; Kizek, R. Mammalian metallothioneins: Properties and functions. Metallomics 2012, 4, 739-750.
3. Günther, V.; Lindert, U.; Schaffner, W. The taste of heavy metals: Gene regulation by MTF-1. Biochim. Biophys. Acta 2012, 1823, 1416-1425.
4. Uchida, Y.; Takio, K.; Titani, K.; Ihara, Y.; Tomonaga, M. The growth inhibitory factor that is deficient in the Alzheimer’s disease brain is a 68 amino acid metallothionein-like protein. Neuron 1991, 7, 337-347.
5. Naruse, S.; Igarashi, S.-I.; Furuya, T.; Kobayashi, H.; Miyatake, T.; Tsuji, S. Structures of the human and mouse growth inhibitory factor-encoding genes. Gene 1994, 144, 283-287.
6. Howells, C.; West, A.K.; Chung, R.S. Neuronal growth-inhibitory factor (metallothionein-3): Evaluation of the biological function of growth-inhibitory factor in the injured and neurodegenerative brain. FEBS J. 2010, 277, 2931-2939.
7. Lee, S.-J.; Cho, K.-S.; Kim, H.N.; Kim, H.-J.; Koh, J.-Y. Role of zinc metallothionein-3 (ZnMt3) in epidermal growth factor (EGF)-induced c-Abl protein activation and actin polymerization in cultured astrocytes. J. Biol. Chem. 2011, 286, 40847-40856.
8. Lee, S.-J.; Seo, B.-R.; Koh, J.-Y. Metallothionein-3 modulates the amyloid β endocytosis of astrocytes through its effects on actin polymerization. Mol. Brain 2015, 8, 84-96.
9. El Ghazi, I.; Martin, B.L.; Armitage, I.M. Metallothionein-3 is a component of a multiprotein complex in the mouse brain. Exp. Biol. Med. 2006, 23, 1500-1506.
10. Lippard, S.J. The inorganic side of chemical biology. Nat. Chem. Biol. 2006, 2, 504-507.
11. Dodani, S.C.; Firl, A.; Chan, J.; Nam, C.I.; Aron, A.T.; Onak, C.S.; Ramos-Torres, K.M.; Paek, J.; Webster, C.M.; Feller, M.B.; et al. Copper is an endogenous modulator of neural circuit spontaneous activity. Proc. Nat. Acad. Sci. USA 2014, 111, 16280-16285.
12. Carpenter, M.C.; Shami Shah, A.; DeSilva, S.; Gleaton, A.; Su, A.; Goundie, B.; Croteau, M.; Stevenson, M.; Wilcox, D.E.; Austin, R.N. Thermodynamics of Pb(II) and Zn(II) binding to MT-3, a neurologically important metallothionein. Metallomics 2016, 8, 605-617.
13. Ordemann, J.M.; Austin, R.N. Lead neurotoxicity: Exploring the potential impact of lead substitution in zinc-finger proteins on metal health. Metallomics 2016, 8, 579-588.
14. Reuben, A.; Caspi, A.; Belsky, D.W.; Broadbent, J.; Harrington, H.; Sugden, K.; Houts, R.M.; Ramrakha, S.; Poulton, R.; Moffitt, T.E. Association of childhood blood lead levels with cognituve function and socioeconomic status at age 38 years and with IQ change and socioeconomic mobility between childhood and adulthood. JAMA 2017, 317, 1244-1251.
15. Chetcuti, A.; Adams, L.J.; Mitchell, P.B.; Schofield, P.R. Microarray gene expression profiling of mouse brain mRNA in a model of lithium treatment. Psychiatr. Genet. 2008, 18, 64-72.
16. Lago, N.; Quintana, A.; Carrasco, J.; Giralt, M.; Hidalgo, J.; Molinero, A. Absence of metallothionein-3 produces changes on MT-1/2 regulation in basal conditions and alters hypothalamic-pituitary-adrenal (HPA) axis. Neurochem. Int. 2014, 74, 65-73.
17. Kramer, K.K.; Liu, J.; Choudhuri, S.; Klaassen, C.D. Induction of metallothionein mRNA and protein in murine astrocyte cultures. Toxicol. Appl. Pharmacol. 1996, 136, 94-100.
18. Zheng, H.; Berman, N.E.J.; Klassen, C.D. Chemical modulation of metallothionein I and III mRNA in mouse brain. Neurochem. Int. 1995, 27, 43-58.
19. Oz, G.; Zangger, K.; Armitage, I.M. Three-dimensional structure and dynamics of a brain specific growth inhibitory factor: Metallothionein-3. Biochemistry 2001, 40, 11433-11441.
20. Vallee, B.L. Implications and Inferences of Metallothionein Structure. In Metallothionein II: Proceedings of the Second International Meeting on Metallothionein and Other Low Molecular Weight Metal-Binding Proteins; Kagi, J.H.R., Kojima, Y., Eds.; Springer: Zurich, Switzerland, 1987; pp. 5-16.
21. Inoue, K.-I.; Takano, H.; Shimada, A.; Satah, M. Metallothionein as an anti-inflammatory mediator. Mediat. Inflamm. 2009, 2009, 101659.
22. Palmiter, R.D. Molecular biology of metallothionein gene expression. In Metallothionein II: Proceedings of the Second International Meeting on Metallothionein and Other Low Molecular Weight Metal-Binding Proteins; Kagi, J.H.R., Kojima, Y., Eds.; Springer: Zurich, Switzerland, 1987; pp. 63-80.
23. Zhang, B.; Georgiev, O.; Hagmann, M.; Günes, Ç.; Cramer, M.; Faller, P.; Vasák, M.; Schaffner, W. Activity of metal-responsive transcription factor 1 by toxic heavy metals and H2O2 in vitro is modulated by metallothionein. Mol. Cell. Biol. 2003, 12, 8471-8485.
24. Yu, J.; Fujishiro, H.; Miyataka, H.; Moyama, T.M.; Hasegawa, T.; Seko, Y.; Miura, N.; Himeno, S. Dichotomous effects of lead acetate on the expression of metallothionein in the liver and kidney of mice. Biol. Pharm. Bull. 2009, 32, 1037-1042.
25. Nascimento, C.R.B.; Risso, W.E.; Bueno dos Reis Martinez, C. Lead accumulation and metallothionein content in female rates of different ages and generations after daily intake of Pb-contaminated food. Environ. Toxicol. Pharmacol. 2016, 48, 272-277.
26. Maitani, T.; Watahiki, A.; Suzuki, K.T. Induction of metallothionein after lead administration by three injection routes in mice. Toxicol. Appl. Pharmacol. 1986, 83, 211-217.
27. Peterson, S.M.; Jun, Z.; Weber, G.; Freeman, J.L. global gene expression analysis reveals dynamic and developmental stage-dependent enrichment of lead-induced neurological gene alterations. Environ. Health Persp. 2011, 119, 615-621.
28. Vignesh, K.S.; Figueroa, J.A.L.; Porollo, A.; Divanovic, S.; Caruso, J.A.; Deepe, G.S.J. IL-4 induces metallothionein 3- and SLC30A4-dependent increase in intracellular Zn2+ that promotes pathogen persistence in macrophages. Cell Rep. 2016, 16, 3232-3246.
29. Amantana, A.; Vorachek, W.R.; Butler, J.A.; Ream, W.; Whanger, P.D. Identification of putative transcription factor binding sites in rodent selenoprotein W promoter. J. Inorg. Biochem. 2004, 98, 1513-1520.
30. Amantana, A.; Vorachek, W.R.; Butler, J.A.; Costa, N.D.; Whanger, P.D. Effect of copper, zinc and cadmium on the promoter of selenorprotein W in glial and myoblast cells. J. Inorg. Biochem. 2002, 91, 356-362.
31. Faraonio, R.; Moffatt, P.; LaRochelle, O.; Schipper, H.M.; S-Arnaud, R.; Séguin, C. Characterization of cis-acting elements in the promoter of the mouse metallothionein-3 gene. Eur. J. Biochem. 2000, 267, 1743-1753.
32. Bartkowska, K.; Swiatek, I.; Aniszewska, A.; Jurewicz, E.; Turlejski, K.; Filipek, A.; Djavadian, R.L. Stress-dependent changes in the CacyBP/SIP interacting protein S100A6 in the mouse brain. PLoS ONE 2017, 12, e0169760.
33. Boom, A.; Pochet, R.; Authelet, M.; Pradier, L.; Borghgraef, P.; Leuven, F.V.; Heizmann, C.W.; Brion, J.-P. Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer’s disease and in PS1/APP transgenic mice models. Biochem. Biophys. Acta 2004, 1741, 161-168.
34. Yamada, J.; Jinno, S. S100A6 (calcyclin) is a novel marker of neural stem cells and astrocyte precursors in the subgranular zone of the adult mouse hippocampus. Hippocampus 2014, 24, 89-101.
35. Carrasco, J.; Penkowa, M.; Giralt, M.; Camats, J.; Molinero, A.; Campbell, I.L.; Palmiter, R.D.; Hidalgo, J. Role of metallothionein-III following central nervous system damage. Neurobiol. Dis. 2003, 13, 22-36.
36. Adam, P.; Krizkoca, S.; Heger, Z.; Babula, P.; Pekarik, V.; Vaculovicova, M.; Gomes, C.M.; Kizek, R.; Adam, V. Metallothioneins in prion and amyloid-related diseases. J. Alzheimers Dis. 2016, 51, 637-656.
37. Uchida, Y. Molecular mechanisms of regeneration in Alzheimer’s disease brain. Geriatr. Gerentol. Int. 2010, 10, S158-S168.
38. Tiu, S.C.; Chan, W.Y.; Heizmann, C.W.; Schafer, B.W.; Shu, S.Y.; Yew, D.T. Differential expression of S100B1 and S100A61 in the human fetal and aged cerebral cortex. Dev. Brain Res. 2000, 119, 159-168.
39. Lesniak, W.; Slomnicki, L.P.; Filipek, A. S100A6—New facts and features. Biochem. Biophys. Res. Commun. 2009, 390, 1087-1092.
40. Weng, Z.; Liu, Z.; Zhang, S.; Tao, H.; Ji, X. Zinc protection in fetal rats for maternal mercury exposure-induced growth retardation is probably associated with S100B expression. J. Obstet. Gynaecol. Res. 2017, 43, 73-77.
41. Seifuddin, F.; Pirooznia, M.; Judy, J.T.; Goes, F.W.; Potash, J.B.; Zandi, P.P. Systematic review of genome-side gene expression studies of bipolar disorder. BMC Psychiatry 2013, 13, 213.
42. Irie, Y.; Itokazua, N.; Anjikia, N.; Ishige, A.; Wantanabe, K.; Keung, W.M. Eugenol exhibits antidepressant-like activity in mice and induces expression of metallothionein-III in the hippocampus. Brain Res. 2004, 1011, 243-246.
43. Choudhuri, S.; Liu, W.L.; Berman, N.E.J.; Klassen, C.D. Cadmium accumulation and metallothionein expression in brain of mice at different stages of development. Toxicol. Lett. 1996, 84, 127-133.
44. Giacconi, R.; Cipriano, C.; Muzzioli, M.; Gasparini, N.; Orlando, F.; Mocchegiani, E. Interrelationships among brain, endocrine and immune response in ageing and successful ageing: Role of metallothionein III isoform. Mech. Ageing Dev. 2003, 124, 371-378.
45. Zeng, J.; Wang, J.; Gao, W.; Mohammadreza, A.; Kelbauskas, L.; Zhang, W.; Johnson, R.H.; Meldrum, D.R. Quantitative single-cell gene expression measurements of multiple genes in response to hypoxia treatment. Anal. Bioanal. Chem. 2011, 401, 3-13.
46. Wang, B.; Wood, I.S.; Trayhurn, P. PCR arrays identify metallothionein-3 as a highly hypoxia-inducible gene in human adipocytes. Biochem. Biophys. Res. Commun. 2008, 368, 88-93.
47. Malairaman, U.; Dandapani, K.; Katyal, A. Effect of Ca2EDTA on the Zinc Mediated inflammation and neuronal apoptosis in hippocampus of an in vivo mouse model of hypobaric hypoxia. PLoS ONE 2014, 9, e110253.
48. Murphy, B.J.; Andrews, G.K.; Bittel, D.; Discher, D.J.; McCue, J.; Green, C.J.; Yanovsky, M.; Giaccia, A.; Sutherland, R.M.; Laderoute, K.R, et al. Activation of metallothionein gene expression by hypoxia involves metal respnse elements and metal transcription factor-1. Cancer Res. 1999, 59, 1315-1322.
49. Hasler, D.W.; Jensen, L.T.; Zerbe, O.; Winge, D.T.; Vasak, M. Effect of the two conserved prolines of human growth inhibitory factor (metallothionein-3) on its biological activity and structure fluctuations: Comparison with a mutant protein. Biochemistry 2000, 39, 14567-14575.
50. Somji, S.; Garrett, S.H.; Sens, M.A.; Sens, D.E. The unique N-terminal sequence of metallothionein-3 is required to regulate the choice between apoptotic or necrotic cell death of human proximal tubule cells exposed to Cd(II). Toxicol. Sci. 2006, 90, 369-376.
51. Presta, A.; Green, A.R.; Zelazowski, A.J.; Stillman, M.J. Copper binding to rabbit liver metallothionein: Formation of a continuum of copper(I)-thiolate stoichiometry species. Eur. J. Biochem. 1995, 227, 226-240.
52. Rigby, K.E.; Chan, J.; Mackie, J.; Stillman, M.J. Molecular dynamics study on the folding and metallation of the individual domains of metallothionein. Proteins Struct. Funct. Bioinform. 2006, 62, 159-172.
53. Sutherland, D.E.K.; Stillman, M.J. The “magic numbers” of metallothionein. Metallomics 2011, 3, 444-463.
54. Palumaa, P.; Tammiste, I.; Kruusel, K.; Kangur, L.; Jornvall, H.; Sillard, R. Metal binding of metallothionein-3 versus metallothionein-2: Lower affinity and higher plasticity. Biochem. Biophys. Acta 2005, 1747, 205-211.
55. Irvine, G.W.; Duncan, K.E.R.; Gullons, M.; Stillman, M.J. Metallation kinetics of the human alpha-metallothionein 1a fragment is dependent on the fluxional structure of the apo protein. Chem. Eur. J. 2015, 21, 1269-1279.
56. Presta, A.; Stillman, M.J. Chiral copper(I)—Thiolate clusters in metallothionein and glutathione. Chirality 1994, 6, 521-530.
57. He, Y.; Lui, M.; Darabedian, N.; Liang, Y.; Wu, D.; Xiang, J.; Zhou, F. pH-Dependent Coordination of Pb2+ to Metallothionein-2: Structures and Insight into Lead Detoxification. Inorg. Chem. 2014, 53, 2822-2830.
58. Chu, D.; Tang, Y.; Huan, Y.; He, W.; Cao, W. The microcalorimetry study on the complexation of lead ion with metallothionein. Thermochim. Acta 2000, 352-353, 205-212.
59. Bridgewater, B.M.; Parkin, G. Lead poisoning and the inactivation of 5-aminolevulinate dehydratase as modeled by the tris(2-mercapto-1-phenylimidazolyl)hydroborato lead complex, {[TmPh]Pb}[ClO4]. J. Am. Chem. Soc. 2000, 122, 7140-7141.
60. Magyar, J.S.; Weng, T.-C.; Stern, C.M.; Dye, D.F.; Rous, B.W.; Payne, J.D.; Bridgewater, B.M.; Mijovilovish, A.; Parkin, G.; Zaleski, J.M. et al. Reexamination of Lead(II) coordination preferences in sulfur-rich sites: Implications for a critical mechanism of lead poisoning. J. Am. Chem. Soc. 2005, 127, 9495-9505.
61. Artells, E.; Palacios, O.; Atrian, S. In vivo-folded metal-metallothionein 3 complexes reveal the Cu-thionein rather than Zn-thionein character of this brain-specific mammalian metallothionein. FEBS J. 2014, 281, 1659-1678.
62. Meloni, G.; Polanski, T.; Braun, O.; Vasak, M. Effects of Zn(II), Ca(II), and Mg(II) on the structure of Zn7metallothionein-3: Evidence for an additional zinc binding site. Biochemistry 2009, 48, 5700-5707.
63. Hagihara, H.; Toyama, K.; Yamasaki, N.; Miyakawa, T. Dissection of hippocampal dentate gyrus from adult mouse. J. Vis. Exp. 2009, 33, e1543.
64. Gentleman, R.C.; Carey, V.J.; Bates, D.M.; Bolstad, B.; Dettling, M.; Dudoit, S.; Ellis, B.; Gautier, L.; Ge, Y.; Gentry, J. et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol. 2004, 5, R80.
65. Irizarry, R.A.; Bolstad, B.M.; Collin, F.; Cope, L.M.; Hobbs, B.; Speed, T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31, e15.
66. Carbon, S.; Ireland, A.; Mungall, C.J.; Shu, S.; Marshall, B.; Lewis, S. AmiGO Hub, Web Presence Working Group. AmiGO: Online access to ontology and annotation data. Bioinformatics 2009, 25, 288-289.
67. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 1995, 57, 289-300.
68. Huang, D.W.; Sherman, B.T.; Lempicki, R.A. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat. Protoc. 2009, 4, 44-57.
69. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2∆∆CT method. Methods 2001, 25, 402-409.
70. Capdevila, M.; Cols, N.; Romero-Isart, N.; Gonzales-Duarte, R.; Atrian, S.; Gonzales-Duarte, P. Recombinant synthesis of mouse Zn3-β and Zn4-α metallothionein 1 domains and characterization of their cadmium (II) binding capacity. Cell. Mol. Life Sci. 1997, 53, 681-688.
71. Cols, N.; Romero-Isart, N.; Capdevila, M.; Oliva, B.; Gonzalez-Duarte, P.; Gonzalez-Duarte, R.; Atrian, S. Binding of excess cadmium(II) to Cd7-metallothionein from recombinant mouse Zn7-metallothionein 1. UV-Vis Absorption and Circular Dichroism studies and theoretical location approach by surface accessibility analysis. J. Inorg. Biochem. 1997, 68, 157-166.
72. Meloni, G.; Knipp, M.; Vasak, M. Detection of neuronal growth inhibitory factor (metallothionein-3) in polyacrylamide gels and by Western blot analysis. J. Biochem. Biophys. Methods 2005, 64, 76-81.